Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
Front Immunol
; 13: 824378, 2022.
Article
in En
| MEDLINE
| ID: mdl-35401544
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Exosomes
/
COVID-19
Type of study:
Guideline
Limits:
Humans
Language:
En
Year:
2022
Type:
Article